Fellow

Redekop E, Wang Z, Kulkarni R, Pleasure M, Chin A, Hassanzadeh HR, Hill BL, Emami M, Speier WF, Arnold CW. Zero-shot medical event prediction using[...]

By afschroeder • October 9, 2025

D'Costa ZU, Qadir N, Parikh RV, Aboulhosn JA, Li A, Shen J, Riahi I, Du AX, Yang EH. Patent Foramen Ovale Closure in Neuroendocrine Prostate[...]

By afschroeder • October 4, 2025

Ara AF, Chenoweth M, Kadiyala S, Essien UR, Scannell C. Racial and Ethnic Disparities in Disease-Modifying Antirheumatic Drug Use Among Adults With Rheumatoid Arthritis in[...]

By afschroeder • October 2, 2025

Vahedi F, Yalamanchi M, Issa D. Endobariatrics in the era of glucagon-like peptide-1 receptor agonists: evolving roles, evidence, and integration. Curr Opin Gastroenterol. 2025 Nov[...]

By afschroeder • October 1, 2025

Truong T, Kaddis T, Wang V, Tsai M, Yusin J. Vibratory Angioedema Due to Vigorous Nose Blowing: A Case Report. Cureus. 2025 Aug 15;17(8):e90197. doi:[...]

By afschroeder • September 18, 2025

Chao E, Marshalek JP, Yashar D, Tomassetti S. Doxorubicin, bleomycin, vinblastine, and dacarbazine for Hodgkin lymphoma: Real-world experience from a Los Angeles County hospital. SAGE[...]

By afschroeder • September 18, 2025

Chao ES, Yoshikawa G, Qing X, Huang C. Hyperferritinemia as a Clue to Neuroendocrine Carcinoma. Cureus. 2025 Aug 13;17(8):e90020. doi: 10.7759/cureus.90020. PMID: 40951183; PMCID: PMC12431798.

By afschroeder • September 16, 2025

Kellner DA, Dente E, Tran V, Welsh T, Tran V, Saha A, Baker JF, Elashoff DA, Ranganath VK. Effect of Glucagon-Like Peptide 1 Receptor Agonists[...]

By afschroeder • September 12, 2025

El Kurdi B, Babar S, Soroush A, Bapaye J, Wasserman RD, Echavarria J, Shahab O, Locke C, Yang J, Koachman M, Mönkemüller K, Shaukat A.[...]

By afschroeder • September 12, 2025

Vahdatpour C, Virk S, Ding H, Epstein S, Jones K, Alneser O, Albanna M, Eagan C, Fu K, Osunnuga O, Zeineddine L, Annis JS, Ebrahimi[...]

By afschroeder • September 11, 2025